# IBRX (Immunitybio, Inc.) - SEC EDGAR Financial Statements

> Immunitybio, Inc. reported $182.6M in revenue and a net loss of $1.11B for the trailing twelve months ended September 30, 2026 (up 52.3% year over year), with a 98.8% gross margin and a -150.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/IBRX
- Markdown: https://convexityos.com/fundamentals/IBRX.md
- SEC CIK: 0001326110
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001326110&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $182.6M | +52.3% YoY |
| Operating Income | TTM | -$274.2M | -150.2% margin |
| Net Income | TTM | -$1.11B | -607.8% net margin |
| Diluted EPS | TTM | -$1.05 | Split-adjusted |
| Free Cash Flow | TTM | -$296.7M | -162.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $334.3M | Total debt: $34.82M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $113.3M | $14.74M | $622K | $240K | $934K | $605K | $2.20M | $47K | $45K | $44K |
| Cost of Revenue | $753K | $0 | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $112.5M | $14.74M | $622K | $240K | -- | -- | -- | -- | -- | -- |
| Research & Development | -- | $190.1M | $232.4M | $248.1M | $196.0M | $139.5M | $112.0M | $55.72M | $42.04M | $29.15M |
| Selling, General & Admin | -- | $168.8M | $129.6M | $102.7M | $135.3M | $71.32M | $46.46M | $42.72M | $57.12M | $95.39M |
| Total Operating Expenses | -- | $358.9M | $362.9M | $351.5M | $331.2M | $221.5M | $158.5M | $98.44M | $99.17M | $124.5M |
| **Operating Income** | -$256.0M | -$344.2M | -$362.2M | -$351.3M | -$330.3M | -$220.9M | -$156.3M | -$98.39M | -$99.12M | -$124.5M |
| **EBITDA** | -$240.5M | -$326.6M | -$343.7M | -$333.0M | -$316.0M | -$208.1M | -$142.2M | -$88.83M | -$93.55M | -$120.9M |
| Interest Income | -- | -- | -- | -- | -- | $1.23M | $1.64M | $2.32M | $4.22M | $5.17M |
| Interest Expense | $60.89M | $114.6M | $128.8M | $63.52M | $14.85M | $9.07M | $5.92M | -- | $618K | $66K |
| Income Before Tax | -$351.6M | -$413.6M | -$583.9M | -$417.3M | -$349.8M | -$226.0M | -$160.3M | -$96.73M | -$96.92M | -$121.4M |
| Income Tax Expense | -$135K | $0 | -$40K | $34K | $9.0K | -$1.85M | -$105K | -$503K | -$493K | -$572K |
| **Net Income** | -$351.4M | -$413.6M | -$583.2M | -$416.6M | -$346.8M | -$221.9M | -$157.8M | -$96.23M | -$96.42M | -$120.8M |
| Basic EPS | -$0.38 | -$0.59 | -$1.15 | -$1.04 | -$0.89 | -$0.59 | -$0.43 | -$1.22 | -$1.20 | -$1.47 |
| **Diluted EPS** | -$0.38 | -$0.62 | -$1.15 | -$1.04 | -$0.89 | -$0.59 | -$0.43 | -$1.22 | -$1.20 | -$1.47 |
| Basic Shares Outstanding | 919.9M | 697.3M | 508.6M | 399.9M | 389.2M | 377.1M | 366.3M | 79.1M | 80.6M | 82.0M |
| Diluted Shares Outstanding | 919.9M | 700.4M | 508.6M | 399.9M | 389.2M | 377.1M | 366.3M | 79.1M | 80.6M | 82.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $48.84M | $51.24M | $44.21M | $38.28M | $32.06M | $26.43M | $16.52M | $7.55M |
| Cost of Revenue | $1.29M | $298K | $238K | $382K | $177K | $136K | $58K | $0 |
| **Gross Profit** | $47.55M | $50.94M | $43.97M | $37.90M | $31.88M | $26.29M | $16.46M | $7.55M |
| Research & Development | -- | -- | -- | -- | -- | -- | -- | $35.22M |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | $41.73M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $76.95M |
| **Operating Income** | -$77.99M | -$61.70M | -$69.79M | -$64.68M | -$55.63M | -$71.28M | -$64.43M | -$69.40M |
| **EBITDA** | -$74.10M | -$57.29M | -$65.41M | -$60.82M | -$51.68M | -$67.41M | -$60.60M | -$65.26M |
| Interest Expense | -- | -- | -- | $14.84M | $15.26M | $15.47M | $15.31M | $26.02M |
| Income Before Tax | -$184.6M | -$230.4M | -$632.8M | -$62.09M | -$67.31M | -$92.31M | -$129.9M | -$59.18M |
| Income Tax Expense | $0 | $0 | $9.0K | -$135K | -$35K | $269K | -$234K | $0 |
| **Net Income** | -$184.6M | -$230.4M | -$632.8M | -$61.94M | -$67.25M | -$92.56M | -$129.6M | -$59.16M |
| Basic EPS | -$0.17 | -$0.22 | -$0.62 | -- | -$0.07 | -$0.10 | -$0.15 | -- |
| **Diluted EPS** | -$0.18 | -$0.22 | -$0.62 | -- | -$0.07 | -$0.10 | -$0.15 | -- |
| Basic Shares Outstanding | 1.06B | 1.05B | 1.03B | -- | 946.6M | 888.2M | 853.2M | -- |
| Diluted Shares Outstanding | 1.06B | 1.05B | 1.03B | -- | 946.6M | 888.2M | 853.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $88.33M | $143.4M | $265.5M | $104.6M | $181.1M | $34.91M | $75.80M | $16.82M | $23.87M | $8.08M |
| Short-Term Investments | $154.5M | $6.38M | $1.01M | $2.54M | $136.0M | $61.15M | $36.14M | $57.33M | $104.3M | $190.8M |
| **Cash & Short-Term Investments** | $242.8M | $149.8M | $266.5M | $107.2M | $317.1M | $96.06M | $111.9M | $74.15M | $128.2M | $198.9M |
| Accounts Receivable, Net | $42.57M | $2.36M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $910K | $8.27M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $2.13M | $1.30M | $1.54M | $1.98M | $2.96M | $110K | $24K | $42K | $275K | $275K |
| **Total Current Assets** | $314.9M | $184.6M | $294.1M | $140.6M | $334.3M | $111.7M | $55.76M | $88.77M | $132.5M | $205.1M |
| Property, Plant & Equipment, Net | $114.3M | $137.1M | $146.1M | $143.7M | $82.86M | $72.54M | $60.50M | $76.89M | $76.73M | $18.91M |
| Goodwill | $910K | $910K | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $12.99M | $14.53M | $17.09M | $20.00M | $1.42M | $1.46M | $0 | $565K | $2.83M | $5.09M |
| Long-Term Investments | -- | $0 | $891K | $840K | $822K | $950K | $1.50M | $5.70M | $29.60M | $87.57M |
| Other Non-Current Assets | -- | $4.83M | $2.88M | $4.86M | $6.78M | $2.60M | $4.39M | $1.53M | $330K | $788K |
| **Total Non-Current Assets** | $187.0M | $198.3M | $210.4M | $221.8M | $134.6M | $109.7M | $87.37M | $93.18M | $118.0M | $112.4M |
| **Total Assets** | $501.9M | $382.9M | $504.5M | $362.4M | $468.9M | $221.4M | $143.1M | $181.9M | $250.4M | $317.5M |
| Accounts Payable | -- | -- | -- | $21.02M | $11.42M | $11.51M | $1.75M | $2.79M | $5.87M | $4.04M |
| Short-Term Debt | $1.75M | $1.25M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | $1.44M | $775K | $1.67M | $1.37M | $891K |
| **Total Current Liabilities** | $61.75M | $54.94M | $58.28M | $500.9M | $369.0M | $68.13M | $11.56M | $27.26M | $20.87M | $12.55M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $166K | $187K |
| Other Non-Current Liabilities | $424K | $319K | $1.11M | $457K | $411K | $1.03M | -- | $0 | $255K | $240K |
| **Total Non-Current Liabilities** | $939.7M | $816.1M | $1.03B | $311.3M | $343.8M | $271.7M | $10.88M | $8.68M | $10.73M | $11.53M |
| **Total Liabilities** | $1.00B | $871.1M | $1.09B | $812.2M | $712.8M | $339.9M | $22.44M | $35.94M | $31.60M | $24.08M |
| **Total Debt (incl. Leases)** | $43.01M | $43.54M | $45.25M | $50.74M | $40.08M | $15.31M | $14.09M | -- | -- | -- |
| Common Stock | $101K | $85K | $67K | $42K | $40K | $38K | $10K | $8.0K | $8.0K | $8.0K |
| Retained Earnings | -$3.73B | -$3.38B | -$2.96B | -$2.38B | -$1.96B | -$1.62B | -$662.2M | -$595.0M | -$498.7M | -$387.1M |
| Accumulated Other Comp. Income | $28.96M | $1.20M | $10K | $183K | $4.0K | $122K | -$105K | -$267K | -$381K | -$284K |
| **Total Stockholders' Equity** | -$500.5M | -$489.1M | -$587.0M | -$447.3M | -$242.2M | -$119.8M | $120.7M | $146.0M | $218.8M | $293.4M |
| Total Equity | -$499.6M | -$488.1M | -$585.9M | -$449.8M | -$243.9M | -$118.5M | $16.33M | $81.94M | $218.8M | $293.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $45.08M | $75.67M | $205.2M | $88.33M | $60.24M | $137.7M | $60.66M | $143.4M |
| Short-Term Investments | $289.2M | $281.7M | $175.7M | $154.5M | $197.6M | $16.00M | $931K | $6.38M |
| **Cash & Short-Term Investments** | $334.3M | $357.4M | $380.9M | $242.8M | $257.8M | $153.7M | $61.59M | $149.8M |
| Accounts Receivable, Net | $53.60M | $53.47M | $43.27M | $42.57M | $32.02M | $22.13M | $17.03M | $2.36M |
| Inventory | $6.0K | $1.94M | $547K | $910K | $6.70M | $6.64M | $8.44M | $8.27M |
| Other Current Assets | -- | -- | $3.02M | $2.13M | $2.51M | $1.64M | $2.35M | $1.30M |
| **Total Current Assets** | $418.8M | $439.0M | $453.0M | $314.9M | $329.5M | $208.1M | $109.2M | $184.6M |
| Property, Plant & Equipment, Net | $115.1M | $114.2M | $112.8M | $114.3M | $129.6M | $133.0M | $135.3M | $137.1M |
| Goodwill | -- | -- | $910K | $910K | $910K | $910K | $910K | $910K |
| Intangible Assets | -- | -- | $11.91M | $12.99M | $13.53M | $13.51M | $14.02M | $14.53M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $4.83M |
| **Total Non-Current Assets** | $190.6M | $189.5M | $193.7M | $187.0M | $189.5M | $193.9M | $194.6M | $198.3M |
| **Total Assets** | $609.4M | $628.5M | $646.6M | $501.9M | $519.0M | $402.1M | $303.8M | $382.9M |
| Short-Term Debt | -- | -- | $884K | $1.75M | $2.60M | -- | -- | $1.25M |
| **Total Current Liabilities** | $98.09M | $76.73M | $67.95M | $61.75M | $57.13M | $50.64M | $49.20M | $54.94M |
| Other Non-Current Liabilities | $1.01M | $510K | $472K | $424K | $702K | $710K | $370K | $319K |
| **Total Non-Current Liabilities** | $1.66B | $1.60B | $1.45B | $939.7M | $985.3M | $921.3M | $845.0M | $816.1M |
| **Total Liabilities** | $1.75B | $1.67B | $1.52B | $1.00B | $1.04B | $971.9M | $894.2M | $871.1M |
| **Total Debt (incl. Leases)** | $34.82M | $38.97M | $41.92M | $43.01M | $44.34M | $43.53M | $40.56M | $43.54M |
| Common Stock | $106K | $105K | $104K | $101K | $98K | $91K | $85K | $85K |
| Retained Earnings | -$4.77B | -$4.59B | -$4.36B | -$3.73B | -$3.66B | -$3.60B | -$3.50B | -$3.38B |
| Accumulated Other Comp. Income | $26.88M | $27.28M | $27.45M | $28.96M | $5.00M | $12.57M | $19.96M | $1.20M |
| **Total Stockholders' Equity** | -$1.15B | -$1.05B | -$870.0M | -$500.5M | -$524.3M | -$570.7M | -$591.4M | -$489.1M |
| Total Equity | -$1.15B | -$1.05B | -$869.1M | -$499.6M | -$523.4M | -$569.8M | -$590.5M | -$488.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$351.5M | -$413.6M | -$583.9M | -$417.3M | -$349.8M | -$224.2M | -$160.2M | -$96.23M | -$96.42M | -$120.8M |
| Depreciation & Amortization | $15.53M | $17.55M | $18.51M | $18.26M | $14.24M | $12.74M | $14.04M | $9.55M | $5.57M | $3.61M |
| Stock-Based Compensation | $36.81M | $34.43M | $49.16M | $40.18M | $57.18M | $2.19M | $3.42M | $23.38M | $37.00M | $73.85M |
| Change in Receivables | -$40.21M | -$2.36M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$6.33M | -$8.27M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$190K | -$3.17M | -$6.48M | $8.00M | -$3.72M | $2.57M | $1.19M | -$1.10M | $150K | $888K |
| **Operating Cash Flow** | -$304.9M | -$391.2M | -$366.8M | -$337.5M | -$274.4M | -$171.7M | -$152.1M | -$63.38M | -$48.78M | -$38.59M |
| Capital Expenditure | -$3.85M | -$6.89M | -$30.58M | -$78.16M | -$33.56M | -$1.67M | -$4.29M | -$13.10M | -$34.81M | -$6.56M |
| **Free Cash Flow** | -$308.8M | -$398.1M | -$397.3M | -$415.7M | -$308.0M | -$173.4M | -$156.4M | -$76.48M | -$83.59M | -$45.15M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Purchases of Investments | -$241.4M | -$140.2M | -$10.36M | -$34.31M | -$141.8M | -$91.57M | -$86.62M | $0 | -$8.50M | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | $73.62M | $112.3M | $165.3M | -- | -- |
| **Investing Cash Flow** | -$149.8M | -$12.25M | -$30.47M | $27.30M | -$84.89M | -$19.81M | $18.55M | $57.10M | $99.55M | -$113.7M |
| Common Stock Issued | -- | -- | -- | $60.43M | $164.5M | $86.30M | $30.00M | $0 | $0 | $0 |
| Share Repurchases | -- | -- | -- | -- | $0 | $0 | -$2.50M | -$228K | -$15.23M | -$15.85M |
| **Financing Cash Flow** | $400.2M | $281.6M | $558.3M | $233.6M | $505.4M | $150.7M | $114.3M | -$771K | -$34.98M | -$15.56M |
| **Net Change in Cash** | -$54.48M | -$121.9M | $160.8M | -$76.31M | $146.2M | -$40.89M | -$19.30M | -$7.05M | $15.79M | -$167.8M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$184.6M | -$230.4M | -$632.8M | -$61.96M | -$67.27M | -$92.57M | -$129.7M | -$59.18M |
| Depreciation & Amortization | $3.89M | $4.41M | $4.38M | $3.87M | $3.95M | $3.88M | $3.83M | $4.14M |
| Stock-Based Compensation | $8.72M | $8.52M | $8.17M | $8.75M | $8.88M | $9.65M | $9.54M | $9.04M |
| Change in Receivables | -$126K | -$10.20M | -$700K | -$10.55M | -$9.89M | -$5.10M | -$14.67M | $1.81M |
| Change in Inventory | -$2.69M | $1.01M | -$4.99M | -$7.89M | -$63K | $1.80M | -$172K | -$6.31M |
| Change in Payables | $1.81M | -$247K | $3.90M | $979K | -$1.39M | -$6.22M | $6.44M | -$3.21M |
| **Operating Cash Flow** | -$75.33M | -$66.49M | -$75.36M | -$70.38M | -$68.91M | -$79.75M | -$85.91M | -$85.14M |
| Capital Expenditure | -$2.93M | -$3.52M | -$1.78M | -$903K | -$741K | -$1.08M | -$1.12M | -$2.11M |
| **Free Cash Flow** | -$78.26M | -$70.01M | -$77.14M | -$71.28M | -$69.65M | -$80.83M | -$87.03M | -$87.25M |
| Purchases of Investments | -$109.5M | -$164.2M | -$139.1M | -$45.63M | -$180.6M | -$15.06M | -$100K | -$6.09M |
| **Investing Cash Flow** | -$8.04M | -$107.5M | -$31.65M | $43.57M | -$181.4M | -$16.14M | $4.13M | $9.83M |
| **Financing Cash Flow** | $53.03M | $44.44M | $223.9M | $54.89M | $173.5M | $172.8M | -$982K | $106.9M |
| **Net Change in Cash** | -$30.59M | -$129.5M | $117.0M | $28.09M | -$76.81M | $77.00M | -$82.77M | $31.61M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 99.3% | 100.0% | 100.0% | 100.0% | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -36509.1% | -7095.9% | -209338.3% | -220266.7% | -282954.5% |
| **Net Profit Margin** | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -36669.6% | -7165.2% | -204736.2% | -214273.3% | -274565.9% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -130.7% | -65.9% | -44.1% | -41.2% |
| Return on Assets (ROA) | -70.0% | -108.0% | -115.6% | -115.0% | -74.0% | -100.2% | -110.2% | -52.9% | -38.5% | -38.1% |
| Current Ratio | 5.10x | 3.36x | 5.05x | 0.28x | 0.91x | 1.64x | 4.82x | 3.26x | 6.35x | 16.34x |
| Quick Ratio | 5.08x | 3.21x | 5.05x | 0.21x | 0.86x | 1.41x | 9.68x | 2.72x | 6.14x | 15.85x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.12x | -- | -- | -- |
| **Revenue Growth (YoY)** | +668.3% | +2270.6% | +159.2% | -74.3% | +54.4% | -72.5% | +4585.1% | +4.4% | +2.3% | -81.4% |
| Gross Profit Growth (YoY) | +663.2% | +2270.6% | +159.2% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +7575.8% | +251.8% | +105.9% | +7.5% | +347.1% | -51.4% | -92.3% | -99.9% | -- | -- |
| 10Y Revenue / Share Growth | +3632.3% | -72.8% | -99.8% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.8% | 99.3% | 99.3% | 99.3% | 99.6% | 99.7% | 99.8% | 100.0% |
| **Operating Margin** | -150.2% | -151.9% | -185.4% | -226.0% | -315.8% | -504.2% | -1003.8% | -2334.2% |
| **Net Profit Margin** | -607.8% | -598.6% | -606.2% | -310.2% | -422.3% | -648.6% | -1310.3% | -2804.8% |
| Return on Assets (ROA) | -182.1% | -157.9% | -132.2% | -70.0% | -67.2% | -91.3% | -134.7% | -108.0% |
| Current Ratio | 4.27x | 5.72x | 6.67x | 5.10x | 5.77x | 4.11x | 2.22x | 3.36x |
| Quick Ratio | 4.27x | 5.70x | 6.66x | 5.08x | 5.65x | 3.98x | 2.05x | 3.21x |
| **Revenue Growth (YoY)** | +52.3% | +93.9% | +167.6% | +407.0% | +425.1% | +2423.9% | +41192.5% | +5333.1% |
| Gross Profit Growth (YoY) | +49.1% | +93.8% | +167.1% | +401.9% | +422.2% | +2410.9% | +41047.5% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
